» Articles » PMID: 15184671

RhoA/Rho-kinase Suppresses Endothelial Nitric Oxide Synthase in the Penis: a Mechanism for Diabetes-associated Erectile Dysfunction

Overview
Specialty Science
Date 2004 Jun 9
PMID 15184671
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Significant impairment in endothelial-derived nitric oxide is present in the diabetic corpus cavernosum. RhoA/Rho-kinase may suppress endothelial nitric oxide synthase (eNOS). Here, we tested the hypothesis that RhoA/Rho-kinase contributes to diabetes-related erectile dysfunction and down-regulation of eNOS in the streptozotocin (STZ)-diabetic rat penis. Colocalization of Rho-kinase and eNOS protein was present in the endothelium of the corpus cavernosum. RhoA/Rho-kinase protein abundance and MYPT-1 phosphorylation at Thr-696 were elevated in the STZ-diabetic rat penis. In addition, eNOS protein expression, cavernosal constitutive NOS activity, and cGMP levels were reduced in the STZ-diabetic penis. To assess the functional role of RhoA/Rho-kinase in the penis, we evaluated the effects of an adeno-associated virus encoding the dominant-negative RhoA mutant (AAVTCMV19NRhoA) on RhoA/Rho-kinase and eNOS and erectile function in vivo in the STZ-diabetic rat. STZ-diabetic rats transfected with AAVCMVT19NRhoA had a reduction in RhoA/Rho-kinase and MYPT-1 phosphorylation at a time when cavernosal eNOS protein, constitutive NOS activity, and cGMP levels were restored to levels found in the control rats. There was a significant decrease in erectile response to cavernosal nerve stimulation in the STZ-diabetic rat. AAVT19NRhoA gene transfer improved erectile responses in the STZ-diabetic rat to values similar to control. These data demonstrate a previously undescribed mechanism for the down-regulation of penile eNOS in diabetes mediated by activation of the RhoA/Rho-kinase pathway. Importantly, these data imply that inhibition of RhoA/Rho-kinase improves eNOS protein content and activity thus restoring erectile function in diabetes.

Citing Articles

The effects of the urotensin-II receptor antagonist palosuran treatment on the corpora cavernosa of streptozotocin-induced diabetic rats.

Olukman M, Can C, Ulker S, Uyanikgil Y, Cavusoglu T, Duzenli N Asian J Urol. 2025; 12(1):116-126.

PMID: 39990066 PMC: 11840324. DOI: 10.1016/j.ajur.2024.02.010.


Idiopathic recurrent ischemic priapism: a review of current literature and an algorithmic approach to evaluation and management.

Yarak N, Khoury J, Coloby P, Bart S, Abdessater M Basic Clin Androl. 2024; 34(1):21.

PMID: 39627696 PMC: 11616154. DOI: 10.1186/s12610-024-00237-y.


Mechanisms of Xuefu Zhuyu Tang in the Treatment of Diabetic Erectile Dysfunction in Rats Through the Regulation of Vascular Endothelial Function by CaSR/PLC/PKC and MEK/ERK/RSK Pathways.

Li X, Zhang M, Feng J, Wang J, Wang K, Ju B Am J Mens Health. 2024; 18(5):15579883241277423.

PMID: 39434501 PMC: 11497541. DOI: 10.1177/15579883241277423.


RhoA/rho kinase pathway activation in age-associated endothelial cell dysfunction and thrombosis.

Palomo I, Wehinger S, Andres V, Garcia-Garcia F, Fuentes E J Cell Mol Med. 2024; 28(8):e18153.

PMID: 38568071 PMC: 10989549. DOI: 10.1111/jcmm.18153.


Hyperprolactinemia and male sexual function: focus on erectile dysfunction and sexual desire.

Corona G, Rastrelli G, Bianchi N, Sparano C, Sforza A, Vignozzi L Int J Impot Res. 2023; 36(4):324-332.

PMID: 37340146 DOI: 10.1038/s41443-023-00717-1.


References
1.
Gong M, Gorenne I, Read P, Jia T, Nakamoto R, Somlyo A . Regulation by GDI of RhoA/Rho-kinase-induced Ca2+ sensitization of smooth muscle myosin II. Am J Physiol Cell Physiol. 2001; 281(1):C257-69. DOI: 10.1152/ajpcell.2001.281.1.C257. View

2.
Rees R, Ralph D, Royle M, Moncada S, Cellek S . Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. Br J Pharmacol. 2001; 133(4):455-8. PMC: 1572821. DOI: 10.1038/sj.bjp.0704124. View

3.
Akingba A, Burnett A . Endothelial nitric oxide synthase protein expression, localization, and activity in the penis of the alloxan-induced diabetic rat. Mol Urol. 2002; 5(4):189-97. DOI: 10.1089/10915360152745885. View

4.
Shimokawa H . Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol. 2002; 39(3):319-27. DOI: 10.1097/00005344-200203000-00001. View

5.
Rees R, Ziessen T, Ralph D, Kell P, Moncada S, Cellek S . Human and rabbit cavernosal smooth muscle cells express Rho-kinase. Int J Impot Res. 2002; 14(1):1-7. DOI: 10.1038/sj.ijir.3900814. View